Chang CY - Search Results

1

4- and 5-aroylindoles as novel classes of potent antitubulin agents.

Liou JP, Wu CY, Hsieh HP, Chang CY, Chen CM, Kuo CC, Chang JY. Liou JP, et al. Among authors: chang jy, chang cy. J Med Chem. 2007 Sep 6;50(18):4548-52. doi: 10.1021/jm070557q. Epub 2007 Aug 8. J Med Chem. 2007. PMID: 17685504

2

Salvinal, a novel microtubule inhibitor isolated from Salvia miltiorrhizae Bunge (Danshen), with antimitotic activity in multidrug-sensitive and -resistant human tumor cells.

Chang JY, Chang CY, Kuo CC, Chen LT, Wein YS, Kuo YH. Chang JY, et al. Among authors: chang cy. Mol Pharmacol. 2004 Jan;65(1):77-84. doi: 10.1124/mol.65.1.77. Mol Pharmacol. 2004. PMID: 14722239

3

Synthesis and structure-activity relationships of 3-aminobenzophenones as antimitotic agents.

Liou JP, Chang JY, Chang CW, Chang CY, Mahindroo N, Kuo FM, Hsieh HP. Liou JP, et al. Among authors: chang cw, chang jy, chang cy. J Med Chem. 2004 May 20;47(11):2897-905. doi: 10.1021/jm0305974. J Med Chem. 2004. PMID: 15139768

4

Cytotoxic triterpenes from the aerial roots of Ficus microcarpa.

Chiang YM, Chang JY, Kuo CC, Chang CY, Kuo YH. Chiang YM, et al. Among authors: chang jy, chang cy. Phytochemistry. 2005 Feb;66(4):495-501. doi: 10.1016/j.phytochem.2004.12.026. Phytochemistry. 2005. PMID: 15694457

5

2-amino and 2'-aminocombretastatin derivatives as potent antimitotic agents.

Chang JY, Yang MF, Chang CY, Chen CM, Kuo CC, Liou JP. Chang JY, et al. Among authors: chang cy. J Med Chem. 2006 Oct 19;49(21):6412-5. doi: 10.1021/jm060616k. J Med Chem. 2006. PMID: 17034147

6

C35 terpenoids from the bark of Calocedrus macrolepis var. formosana with activity against human cancer cell lines.

Hsieh CL, Tseng MH, Shao YY, Chang JY, Kuo CC, Chang CY, Kuo YH. Hsieh CL, et al. Among authors: chang jy, chang cy. J Nat Prod. 2006 Nov;69(11):1611-3. doi: 10.1021/np0600550. J Nat Prod. 2006. PMID: 17125231

7

7-Aroyl-aminoindoline-1-sulfonamides as a novel class of potent antitubulin agents.

Chang JY, Hsieh HP, Chang CY, Hsu KS, Chiang YF, Chen CM, Kuo CC, Liou JP. Chang JY, et al. Among authors: chang cy. J Med Chem. 2006 Nov 16;49(23):6656-9. doi: 10.1021/jm061076u. J Med Chem. 2006. PMID: 17154496

8

A novel oral indoline-sulfonamide agent, N-[1-(4-methoxybenzenesulfonyl)-2,3-dihydro-1H-indol-7-yl]-isonicotinamide (J30), exhibits potent activity against human cancer cells in vitro and in vivo through the disruption of microtubule.

Liou JP, Hsu KS, Kuo CC, Chang CY, Chang JY. Liou JP, et al. Among authors: chang jy, chang cy. J Pharmacol Exp Ther. 2007 Oct;323(1):398-405. doi: 10.1124/jpet.107.126680. Epub 2007 Jul 27. J Pharmacol Exp Ther. 2007. PMID: 17660383

9

Discovery of 4-amino and 4-hydroxy-1-aroylindoles as potent tubulin polymerization inhibitors.

Liou JP, Wu ZY, Kuo CC, Chang CY, Lu PY, Chen CM, Hsieh HP, Chang JY. Liou JP, et al. Among authors: chang jy, chang cy. J Med Chem. 2008 Jul 24;51(14):4351-5. doi: 10.1021/jm800150d. Epub 2008 Jun 28. J Med Chem. 2008. PMID: 18588280

10

Synthesis and structure-activity relationships of 2-amino-1-aroylnaphthalene and 2-hydroxy-1-aroylnaphthalenes as potent antitubulin agents.

Reddy GR, Kuo CC, Tan UK, Coumar MS, Chang CY, Chiang YK, Lai MJ, Yeh JY, Wu SY, Chang JY, Liou JP, Hsieh HP. Reddy GR, et al. Among authors: chang jy, chang cy. J Med Chem. 2008 Dec 25;51(24):8163-7. doi: 10.1021/jm8008635. J Med Chem. 2008. PMID: 19053773

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,961 results

Search Page

Filters